T-Type voltage gated calcium channels: a target in breast cancer?

Anamika Bhargava1, Sumit Saha2

  • 1Ion Channel Biology Lab, Department of Biotechnology, Indian Institute of Technology Hyderabad (IITH), Kandi, Telangana, 502285, India. abhargava@iith.ac.in.

Abstract

Insights

T-type voltage-gated calcium channels (VGCCs) show potential as breast cancer drug targets. Research indicates VGCC antagonists inhibit growth, while CaV3.1 may suppress tumors, warranting further investigation for targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Breast cancer necessitates novel therapeutic strategies due to its high mortality rate across diverse molecular subtypes.
  • Voltage-gated calcium channels (VGCCs) regulate intracellular calcium, influencing key cellular processes including tumorigenesis and cancer progression.
  • T-type VGCCs have emerged as a focus in breast cancer research, with general calcium channel blockers demonstrating anti-proliferative and cytotoxic effects.

Purpose of the Study:

  • To review the potential of T-type voltage-gated calcium channels (VGCCs) as viable drug targets for breast cancer treatment.
  • To explore the role of specific T-type VGCC isoforms (CaV3.1 and CaV3.2) in breast cancer proliferation and tumor suppression.
  • To discuss the implications of T-type VGCCs in breast cancer metastasis, epithelial-to-mesenchymal transition (EMT), and the potential of combination therapies.

Main Methods:

  • Literature review of studies investigating T-type VGCCs in breast cancer.
  • Analysis of research on the effects of T-type VGCC antagonists on cancer cell proliferation.
  • Examination of findings related to CaV3.1 and CaV3.2 isoforms in breast cancer contexts.

Main Results:

  • T-type VGCC antagonists exhibit anti-proliferative effects, particularly through CaV3.2 isoform inhibition.
  • The CaV3.1 isoform shows promise as a tumor suppressor, supporting anti-proliferative and apoptotic activities in breast cancer.
  • The distribution and specific roles of T-type VGCC isoforms in different breast cancer subtypes and metastatic processes require further elucidation.

Conclusions:

  • T-type VGCCs represent a promising area for developing new breast cancer therapeutics.
  • Further research, including isoform-specific studies and clinical trials, is essential to validate T-type VGCC blockers as a targeted therapy.
  • Combination therapies involving chemotherapy and T-type VGCC blockers may offer a potent strategy for improving breast cancer treatment outcomes.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
10.9K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
8.3K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
7.8K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
14.4K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.0K